Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients
NCT04860297Phase 3Completed
- Sponsor
- Moderna Inc
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Moderna Inc. Started Apr 2021; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04860297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860297.